Healthcare provider profile · identity verified

Ronald E Greer, MD

Family Practice · RAVENSWOOD, WV · NPI 1962616771

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	690	200
Levothyroxine Sodium	Levothyroxine Sodium	375	110
Amlodipine Besylate	Amlodipine Besylate	342	108
Losartan Potassium	Losartan Potassium	300	89
Lisinopril	Lisinopril	274	92
Metoprolol Succinate	Metoprolol Succinate	237	72
Pantoprazole Sodium	Pantoprazole Sodium	236	74
Rosuvastatin Calcium	Rosuvastatin Calcium	214	73
Omeprazole	Omeprazole	194	65
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	148	46
Clopidogrel	Clopidogrel Bisulfate	143	44
Metoprolol Tartrate	Metoprolol Tartrate	143	48
Alendronate Sodium	Alendronate Sodium	120	40
Metformin Hcl	Metformin Hcl	120	40
Eliquis	Apixaban	119	29
Famotidine	Famotidine	111	31
Albuterol Sulfate Hfa	Albuterol Sulfate	110	52
Meloxicam	Meloxicam	105	32
Synthroid	Levothyroxine Sodium	104	26
Gabapentin	Gabapentin	99	41
Ezetimibe	Ezetimibe	95	34
Hydrochlorothiazide	Hydrochlorothiazide	95	32
Allopurinol	Allopurinol	92	30
Tamsulosin Hcl	Tamsulosin Hcl	89	28
Ozempic	Semaglutide	87	24
Montelukast Sodium	Montelukast Sodium	83	18
Fluticasone Propionate	Fluticasone Propionate	77	28
Hydralazine Hcl	Hydralazine Hcl	77	22
Potassium Chloride	Potassium Chloride	77	19
Sertraline Hcl	Sertraline Hcl	75	24
Prednisone	Prednisone	73	49
Spironolactone	Spironolactone	73	21
Furosemide	Furosemide	71	25
Trazodone Hcl	Trazodone Hcl	69	31
Escitalopram Oxalate	Escitalopram Oxalate	68	24
Duloxetine Hcl	Duloxetine Hcl	67	25
Jardiance	Empagliflozin	66	23
Finasteride	Finasteride	65	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	20
Buspirone Hcl	Buspirone Hcl	64	21
Carvedilol	Carvedilol	64	22
Citalopram Hbr	Citalopram Hydrobromide	64	17
Esomeprazole Magnesium	Esomeprazole Magnesium	57	18
Farxiga	Dapagliflozin Propanediol	57	14
Januvia	Sitagliptin Phosphate	56	16
Fenofibrate	Fenofibrate Nanocrystallized	55	18
Atenolol	Atenolol	52	16
Trulicity	Dulaglutide	51	17
Metformin Hcl Er	Metformin Hcl	48	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	18
Terbinafine Hcl	Terbinafine Hcl	45	suppressed
Bupropion Xl	Bupropion Hcl	44	15
Amitriptyline Hcl	Amitriptyline Hcl	43	16
Glimepiride	Glimepiride	43	14
Tizanidine Hcl	Tizanidine Hcl	42	19
Nitroglycerin	Nitroglycerin	41	33
Celecoxib	Celecoxib	40	11
Ibuprofen	Ibuprofen	39	17
Warfarin Sodium	Warfarin Sodium	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Mounjaro	Tirzepatide	35	11
Ropinirole Hcl	Ropinirole Hcl	35	15
Valsartan	Valsartan	35	13
Xarelto	Rivaroxaban	35	suppressed
Cefdinir	Cefdinir	33	27
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	12
Pioglitazone Hcl	Pioglitazone Hcl	32	12
Tramadol Hcl	Tramadol Hcl	29	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Fluconazole	Fluconazole	25	13
Entresto	Sacubitril/Valsartan	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	15
Naproxen	Naproxen	22	suppressed
Ondansetron Odt	Ondansetron	21	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	suppressed
Lorazepam	Lorazepam	20	12
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	12
Verapamil Er	Verapamil Hcl	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Estradiol	Estradiol	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Primidone	Primidone	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Temazepam	Temazepam	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Glipizide	Glipizide	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Torsemide	Torsemide	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error